Fredun Pharmaceuticals , a pharma formulation manufacturing company, has reported that its net profit more than doubled in the September quarter to ₹10 crore and its income jumped 35 per cent to ₹145 crore. EBITDA was up 60 per cent at ₹22 crore.

Fredun Medhora, Managing Director, said the domestic formulations business delivered a solid performance through new product introductions and rising institutional demand, while exports maintained steady traction.

“We have commenced expansion of our manufacturing facility at Palghar to enhance capacity, improve operational efficiency and support the growing demand across both domestic and international markets,” he said.

The launch of Snacky Jain — India’s first Jain functional food for pets — received an overwhelming response, with the entire

See Full Page